Clinical results of treatment with E. coli L‐asparaginase in adults with leukemia, lymphoma, and solid tumors

Cancer

Volumn 25, Issue 2, 1970, Pages 279-305

  Clarkson, Bayard ^a,b   Krakoff, Irwin ^a,b   Burchenal, Joseph ^a,b   Karnofsky, David ^a,b   Golbey, Robert ^a,b   Dowling, Monroe ^a,b   Oettgen, Herbert ^a,b   Lipton, Allan ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Psychiatry and Behavioral Sciences Psychiatry Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ENZYMOLOGY; ESCHERICHIA COLI; FEMALE; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; HUMAN; HYPERSENSITIVITY; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOMA; MALE; MELANOMA; MYELOID LEUKEMIA; NONHODGKIN LYMPHOMA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ASPARAGINASE; ESCHERICHIA COLI; FEMALE; HODGKIN DISEASE; HUMAN; HYPERSENSITIVITY; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; LYMPHOMA; LYMPHOMA, LARGE-CELL; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MIDDLE AGE;

EID: 0014733901     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(197002)25:2<279::AID-CNCR2820250205>3.0.CO;2-7     Document Type: Article

References (33)

1. Suppression of murine leukemias by L‐asparaginase
2. Evidence that the L‐asparaginase activity of guinea pig serum is responsible for its anti‐lymphoma effects
3. Studies on the mechanism of tumor inhibition by L‐asparaginase
4. Two L‐asparaginases from Escherichia coli B. Their separation, purification and antitumor activity
5. Treatment of adult acute leukemia with arabinosylcytosine and thioguanine
6. Asparagine synthetase in human leukemia: a mechanism of resistance to L‐asparaginase
7. The Midwest Chemotherapy Group. Phase II Study of A‐8103 (NSC‐25154) in Acute Leukemia in Adults. Appendix
8. L‐asparaginase therapy for leukemia and other malignant neoplasmas. Remission in human leukemia
9. Asparagine synthetase activity of mouse leukemias
10. Meaningful clinical classification of therapeutic responses to anticancer drugs
11. Remissions induced in trophoblastic tumors by 6‐diazo‐5‐oxo‐1‐norleucine (DON)
12. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum
13. Inhibition of HeLa cell cultures by preparations of Escherichia coli L‐asparaginase
14. Tumor inhibitory effect of L‐asparaginase from Escherichia coli
15. Amino acid levels following L‐asparagine amidohydrolase (EC 3511) therapy
16. Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine
17. Treatment of leukemias and lymphomas in adults with E. coli L‐Asparaginase (A‐ase)
18. Inhibition of leukemia in man by L‐asparaginase
19. Hemmung maligner neoplasiendes menschen durch L‐Asparaginase
20. The toxicity of E. coli L‐Asparaginase in man
21. Leukemia‐inhibitory properties and L‐asparaginase activity of sera from certain S.A. rodents
22. Asparaginase synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparaginase
23. Experience with the subcutaneous cerebrospinal‐fluid reservoir
24. The antitumor activity of Escherichia coli L‐asparaginase
25. Report of the committee on the staging of Hodgkin's disease
26. L‐asparaginase activity in plasma and other biological fluids
27. Two L‐asparaginases from E. coli and their action against tumors
28. A metabolic difference between two lines of lymphoma 6C3HED cells in relation to asparagine
29. Treatment of 131 children with acute leukemia and solid tumors with E. coli L‐asparaginase